Transrectal Ultrasound Market
Transrectal Ultrasound Market Forecasts to 2032 - Global Analysis By Product (Systems and Transducers), Technology (2D Ultrasound, 3D/4D Ultrasound, Doppler Ultrasound and Contrast-Enhanced Ultrasound (CEUS)), Application, End User and By Geography
|
Years Covered |
2024-2032 |
|
Estimated Year Value (2025) |
US $263.9 MN |
|
Projected Year Value (2032) |
US $402.1 MN |
|
CAGR (2025-2032) |
6.2% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Transrectal Ultrasound Market is accounted for $263.9 million in 2025 and is expected to reach $402.1 million by 2032, growing at a CAGR of 6.2% during the forecast period. Transrectal ultrasound (TRUS), a medical imaging method, primarily examines the prostate gland. A tiny ultrasound probe is inserted into the rectum to create detailed images using sound waves. TRUS helps diagnose prostate disorders, direct biopsies, and assess anomalies like enlargement or tumors. It is a widely used, safe, and minimally invasive method for identifying urological conditions, including prostate cancer.
According to data published by the American Cancer Society, approximately 288,300 men in the U.S. were estimated to be diagnosed with prostate cancer by the end of 2024
Market Dynamics:
Driver:
Increasing prevalence of prostate cancer
One major factor propelling the transrectal ultrasound (TRUS) industry is the increasing incidence of prostate cancer worldwide. Because TRUS allows for precise lesion localization and early identification, it is essential in the diagnosis of prostate cancer. Demand has also gone up because new imaging technologies, like real-time elastography and MRI-US fusion biopsies, have made diagnosis more accurate. The market is also growing as a result of enhanced healthcare infrastructure in emerging nations and government financing for prostate cancer research. When taken as a whole, these elements make TRUS a vital instrument for combating the rising incidence of prostate cancer.
Restraint:
Availability of alternative imaging techniques
The availability of substitute imaging modalities, such as multiparametric MRI (mpMRI), constrains the TRUS market. Multiparametric MRI (mpMRI) is often the preferred option due to its enhanced visibility of prostate lesions and its ability to reduce the detection of tumors that are not clinically significant. Also, when used with targeted biopsy methods, mpMRI has been found to be more accurate in diagnosing compared to regular TRUS-guided biopsies. TRUS's potential for expansion is constrained by the growing use of these cutting-edge imaging techniques, particularly in areas with established healthcare systems.
Opportunity:
Integration with targeted biopsy techniques
Combining TRUS with targeted biopsy methods like MRI-US fusion biopsies presents a significant opportunity for growth. By facilitating real-time imaging and accurate targeting of worrisome lesions, this combination improves the detection accuracy of prostate cancer. Furthermore, improvements in micro-ultrasound technology provide imaging with higher resolution, which enhances diagnostic results even more. These developments are propelling a change from traditional diagnostic techniques to more sophisticated ones, opening up new market potential prospects.
Threat:
Cost and reimbursement issues
The high expenses of sophisticated TRUS systems and restrictive reimbursement guidelines threaten the market's expansion. The cost of these gadgets continues to be a problem for healthcare practitioners in many areas, especially in poor nations. Furthermore, strict regulatory requirements and product recalls triggered by safety concerns may hinder market expansion.
Covid-19 Impact:
The COVID-19 epidemic negatively impacted the transrectal ultrasound market by causing disruptions in healthcare services. Prostate cancer diagnostic procedures decreased as a result of strict social distancing measures and fewer hospital visits. The pandemic's drop in demand was also due to worries about ultrasound technology spreading infections. Nonetheless, the industry is anticipated to regain momentum and show steady development in the post-pandemic phase as healthcare institutions recover and implement improved safety measures.
The hospitals segment is expected to be the largest during the forecast period
The hospitals segment is expected to account for the largest market share during the forecast period because of their sophisticated infrastructure and abundance of qualified personnel. Patients choose hospital-based diagnoses and treatments due to the rising incidence of prostate-related illnesses. Additionally, hospitals frequently have access to state-of-the-art imaging technologies such as MRI fusion capabilities or high-resolution TRUS systems with real-time elastography. Both public and private hospitals, catering to various patient demands, guarantee their dominant position in this market segment.
The 3D/4D ultrasound segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the 3D/4D ultrasound segment is predicted to witness the highest growth rate. This is due to its enhanced imaging capabilities, which enable accurate observation of prostate architecture. These cutting-edge devices provide real-time images with improved quality and accuracy, facilitating better diagnosis. Their combination with focused biopsy procedures further enhances clinical results. The development of imaging technology and the increasing need for novel approaches to prostate cancer diagnostics are the main drivers of this market's explosive expansion.
Region with largest share:
During the forecast period, the North America region is expected to hold the largest market share because of its established healthcare system and high incidence of prostate cancer. Considerable funds are allocated to research and development initiatives to enhance diagnostic technologies in the region. Strong market demand is also a result of attractive reimbursement regulations and high awareness of early-stage disease identification. Major industry companies guarantee access to cutting-edge TRUS systems in hospitals and diagnostic facilities, which is fueling the growth in the region.
Region with highest CAGR:
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. This is due to the increasing awareness of early prostate disease diagnosis and the rising healthcare costs in countries such as China and India. As age-related prostate disorders become more common, the region's growing geriatric population base increases demand for TRUS equipment. Furthermore, government programs encouraging the adoption of medical technology and improvements to healthcare infrastructure are driving market expansion throughout Asia Pacific.
Key players in the market
Some of the key players in Transrectal Ultrasound Market include Echo-Son SA, Esaote SpA, Exact Imaging, Fujifilm Holdings Corporation, GE Healthcare, KOELIS, Koninklijke Philips N.V., Siemens Healthineers AG, Sonablate Corp, The Prometheus Group, EDAP TMS SA, Strata Imaging, HALO Medical Technologies, Telemed Medical Systems, BK Medical, and Bracco Imaging S.p.A.
Key Developments:
In November 2024, EDAP TMS SA announced positive clinical results regarding its robotic High-Intensity Focused Ultrasound (HIFU) treatment for deep infiltrating endometriosis at the 2024 AAGL Global Congress. A study presented by Professor Gil Dubernard compared the outcomes of HIFU therapy to traditional surgical methods, revealing that patients undergoing HIFU experienced significantly reduced moderate and severe postoperative complications, shorter hospital stays, and improved overall health. The study analyzed data from 120 patients and found that HIFU could serve as a less invasive alternative to surgery, addressing a condition with limited treatment options. The company is working on further evaluations and plans to discuss these findings with the FDA as it advances its Phase 3 trial for HIFU treatment.
In September 2024, Koelis, SAS, a global leader and innovator in prostate care, announced the release of a new, compact 3D transducer for transperineal fusion biopsy and treatment. Koelis is now compatible with both the market leading high-level disinfection systems (Trophon® and Astra®VR).
In March 2024, GE HealthCare (Nasdaq: GEHC) announced the launch of Prostate Volume Assist (PVA) urology-based artificial intelligence (AI) software feature. As a global leader in ultrasound-guided solutions in urology, this AI-based software feature is designed to support clinicians in prostate imaging, biopsies and guiding treatment. This new feature assists urologists by offering a solution that improves workflow and quickly captures prostate volume. The added functionality with PVA can determine calculations and measurements of the organ with an automated, one-click process.
Product Covered:
• Systems
• Transducers
Technologies Covered:
• 2D Ultrasound
• 3D/4D Ultrasound
• Doppler Ultrasound
• Contrast-Enhanced Ultrasound (CEUS)
Applications Covered:
• Prostate Cancer
• Benign Prostatic Hyperplasia (BPH)
• Male Infertility Diagnosis
• Other Applications
End Users Covered:
• Hospitals
• Diagnostic Imaging Centers
• Urology Clinics
• Ambulatory Surgical Centers (ASCs)
• Academic & Research Institutes
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Technology Analysis
3.8 Application Analysis
3.9 End User Analysis
3.10 Emerging Markets
3.11 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Transrectal Ultrasound Market, By Product
5.1 Introduction
5.2 Systems
5.2.1 Cart-Based Systems
5.2.2 Portable/Handheld Systems
5.3 Transducers
6 Global Transrectal Ultrasound Market, By Technology
6.1 Introduction
6.2 2D Ultrasound
6.3 3D/4D Ultrasound
6.4 Doppler Ultrasound
6.5 Contrast-Enhanced Ultrasound (CEUS)
7 Global Transrectal Ultrasound Market, By Application
7.1 Introduction
7.2 Prostate Cancer
7.3 Benign Prostatic Hyperplasia (BPH)
7.4 Male Infertility Diagnosis
7.5 Other Applications
8 Global Transrectal Ultrasound Market, By End User
8.1 Introduction
8.2 Hospitals
8.3 Diagnostic Imaging Centers
8.4 Urology Clinics
8.5 Ambulatory Surgical Centers (ASCs)
8.6 Academic & Research Institutes
9 Global Transrectal Ultrasound Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Echo-Son SA
11.2 Esaote SpA
11.3 Exact Imaging
11.4 Fujifilm Holdings Corporation
11.5 GE Healthcare
11.6 KOELIS
11.7 Koninklijke Philips N.V.
11.8 Siemens Healthineers AG
11.9 Sonablate Corp
11.10 The Prometheus Group
11.11 EDAP TMS SA
11.12 Strata Imaging
11.13 HALO Medical Technologies
11.14 Telemed Medical Systems
11.15 BK Medical
11.16 Bracco Imaging S.p.A.
List of Tables
1 Global Transrectal Ultrasound Market Outlook, By Region (2024-2032) ($MN)
2 Global Transrectal Ultrasound Market Outlook, By Product (2024-2032) ($MN)
3 Global Transrectal Ultrasound Market Outlook, By Systems (2024-2032) ($MN)
4 Global Transrectal Ultrasound Market Outlook, By Cart-Based Systems (2024-2032) ($MN)
5 Global Transrectal Ultrasound Market Outlook, By Portable/Handheld Systems (2024-2032) ($MN)
6 Global Transrectal Ultrasound Market Outlook, By Transducers (2024-2032) ($MN)
7 Global Transrectal Ultrasound Market Outlook, By Technology (2024-2032) ($MN)
8 Global Transrectal Ultrasound Market Outlook, By 2D Ultrasound (2024-2032) ($MN)
9 Global Transrectal Ultrasound Market Outlook, By 3D/4D Ultrasound (2024-2032) ($MN)
10 Global Transrectal Ultrasound Market Outlook, By Doppler Ultrasound (2024-2032) ($MN)
11 Global Transrectal Ultrasound Market Outlook, By Contrast-Enhanced Ultrasound (CEUS) (2024-2032) ($MN)
12 Global Transrectal Ultrasound Market Outlook, By Application (2024-2032) ($MN)
13 Global Transrectal Ultrasound Market Outlook, By Prostate Cancer (2024-2032) ($MN)
14 Global Transrectal Ultrasound Market Outlook, By Benign Prostatic Hyperplasia (BPH) (2024-2032) ($MN)
15 Global Transrectal Ultrasound Market Outlook, By Male Infertility Diagnosis (2024-2032) ($MN)
16 Global Transrectal Ultrasound Market Outlook, By Other Applications (2024-2032) ($MN)
17 Global Transrectal Ultrasound Market Outlook, By End User (2024-2032) ($MN)
18 Global Transrectal Ultrasound Market Outlook, By Hospitals (2024-2032) ($MN)
19 Global Transrectal Ultrasound Market Outlook, By Diagnostic Imaging Centers (2024-2032) ($MN)
20 Global Transrectal Ultrasound Market Outlook, By Urology Clinics (2024-2032) ($MN)
21 Global Transrectal Ultrasound Market Outlook, By Ambulatory Surgical Centers (ASCs) (2024-2032) ($MN)
22 Global Transrectal Ultrasound Market Outlook, By Academic & Research Institutes (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We offer complimentary customization of up to 15% with every purchase. To share your customization requirements, feel free to email us at info@strategymrc.com or call us on +1-301-202-5929. .
Please Note: Customization within the 15% threshold is entirely free of charge. If your request exceeds this limit, we will conduct a feasibility assessment. Following that, a detailed quote and timeline will be provided.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
